Template:Erythrasma: Difference between revisions
Jump to navigation
Jump to search
Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''E..." |
No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 23: | Line 23: | ||
! | ! | ||
[[Erythrasma overview|Overview]] | [[Erythrasma overview|Overview]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Erythrasma historical perspective|Historical Perspective]] | |||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Erythrasma classification|Classification]] | |||
|- | |- | ||
! | ! | ||
| Line 40: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | [[Differentiating erythrasma from other diseases|Differentiating Erythrasma from other Diseases]] | ||
|- | |- | ||
! | ! | ||
| Line 47: | Line 59: | ||
! | ! | ||
[[Erythrasma epidemiology and demographics|Epidemiology and Demographics]] | [[Erythrasma epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Erythrasma risk factors|Risk Factors]] | |||
|- | |- | ||
! | ! | ||
| Line 83: | Line 101: | ||
! | ! | ||
[[Erythrasma laboratory findings|Laboratory Findings]] | [[Erythrasma laboratory findings|Laboratory Findings]] | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Erythrasma electrocardiogram|Electrocardiogram]] | |||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Erythrasma x ray|X Ray]] | |||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Erythrasma CT|CT]] | |||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Erythrasma MRI|MRI]] | |||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Erythrasma echocardiography or ultrasound|Echocardiography or Ultrasound]] | |||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Erythrasma other imaging findings|Other Imaging Findings]] | |||
|- | |- | ||
! | ! | ||
| Line 101: | Line 155: | ||
! | ! | ||
[[Erythrasma medical therapy|Medical Therapy]] | [[Erythrasma medical therapy|Medical Therapy]] | ||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Erythrasma surgery|Surgery]] | |||
|- | |- | ||
! | ! | ||
| Line 113: | Line 173: | ||
! | ! | ||
[[Erythrasma secondary prevention|Secondary Prevention]] | [[Erythrasma secondary prevention|Secondary Prevention]] | ||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Erythrasma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Erythrasma future or investigational therapies|Future or Investigational Therapies]] | |||
|- | |- | ||
! | ! | ||
Latest revision as of 17:47, 30 September 2016
|
Erythrasma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Erythrasma On the Web |
|
American Roentgen Ray Society Images of Erythrasma |